Open AccessFirst‐Line Chemotherapy for Ovarian Cancer: Inferences From Recent Studies
Author(s) -
Rose Peter G.
Publication year - 2016
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2016-0144
Subject(s) - medicine , taxane , ovarian cancer , oncology , chemotherapy , first line , standard of care , clinical trial , cancer , gynecology , breast cancer
This review discusses the evolution of platinum and taxane first‐line chemotherapy for ovarian cancer and the most recent trials and their impact on the current standard of care.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom